Successful Retreatment of Glecaprevir-Pibrentasvir for Hepatitis C Virus Genotype 2a Infection in Patient Whose Cirrhosis Improved From Decompensation to Compensation After Sofosbuvir–Velpatasvir Therapy

Tatsuo Kanda; Ryota Masuzaki; Naoki Matsumoto; Reina Sasaki-Tanaka; Hirofumi Kogure

doi:10.1111/hepr.70046

Successful Retreatment of Glecaprevir-Pibrentasvir for Hepatitis C Virus Genotype 2a Infection in Patient Whose Cirrhosis Improved From Decompensation to Compensation After Sofosbuvir–Velpatasvir Therapy

Tatsuo Kanda
, Ryota Masuzaki
, Naoki Matsumoto
, Reina Sasaki-Tanaka
, Hirofumi Kogure

School of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	253-255
Number of pages	3
Journal	Hepatology Research
Volume	56
Issue number	2
DOIs	https://doi.org/10.1111/hepr.70046
Publication status	Published - Feb 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

DAA
HCV
decompensated cirrhosis
retreatment
sustained virologic response

Access to Document

10.1111/hepr.70046

Cite this

@article{f540a74fbe4643fd8b55484112977d90,

title = "Successful Retreatment of Glecaprevir-Pibrentasvir for Hepatitis C Virus Genotype 2a Infection in Patient Whose Cirrhosis Improved From Decompensation to Compensation After Sofosbuvir–Velpatasvir Therapy",

keywords = "DAA, HCV, decompensated cirrhosis, retreatment, sustained virologic response",

author = "Tatsuo Kanda and Ryota Masuzaki and Naoki Matsumoto and Reina Sasaki-Tanaka and Hirofumi Kogure",

year = "2026",

month = feb,

doi = "10.1111/hepr.70046",

language = "English",

volume = "56",

pages = "253--255",

journal = "Hepatology Research",

issn = "1386-6346",

publisher = "John Wiley and Sons Inc.",

number = "2",

}

Successful Retreatment of Glecaprevir-Pibrentasvir for Hepatitis C Virus Genotype 2a Infection in Patient Whose Cirrhosis Improved From Decompensation to Compensation After Sofosbuvir–Velpatasvir Therapy. / Kanda, Tatsuo; Masuzaki, Ryota ; Matsumoto, Naoki et al.
In: Hepatology Research, Vol. 56, No. 2, 02.2026, p. 253-255.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Successful Retreatment of Glecaprevir-Pibrentasvir for Hepatitis C Virus Genotype 2a Infection in Patient Whose Cirrhosis Improved From Decompensation to Compensation After Sofosbuvir–Velpatasvir Therapy

AU - Kanda, Tatsuo

AU - Masuzaki, Ryota

AU - Matsumoto, Naoki

AU - Sasaki-Tanaka, Reina

AU - Kogure, Hirofumi

PY - 2026/2

Y1 - 2026/2

KW - DAA

KW - HCV

KW - decompensated cirrhosis

KW - retreatment

KW - sustained virologic response

UR - https://www.scopus.com/pages/publications/105017378920

U2 - 10.1111/hepr.70046

DO - 10.1111/hepr.70046

M3 - Letter

AN - SCOPUS:105017378920

SN - 1386-6346

VL - 56

SP - 253

EP - 255

JO - Hepatology Research

JF - Hepatology Research

IS - 2

ER -

Successful Retreatment of Glecaprevir-Pibrentasvir for Hepatitis C Virus Genotype 2a Infection in Patient Whose Cirrhosis Improved From Decompensation to Compensation After Sofosbuvir–Velpatasvir Therapy

UN SDGs

Keywords

Access to Document

Other files and links

Cite this